258 related articles for article (PubMed ID: 18388689)
1. Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.
Yong EL; Li J; Liu MH
Curr Opin Lipidol; 2008 Apr; 19(2):106-12. PubMed ID: 18388689
[TBL] [Abstract][Full Text] [Related]
2. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Tönjes A; Stumvoll M
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
[TBL] [Abstract][Full Text] [Related]
3. [Gene-diet interactions in atherogenic dyslipidemias (part 2)].
Zák A; Slabý A
Cas Lek Cesk; 2007; 146(12):902-8. PubMed ID: 18257402
[TBL] [Abstract][Full Text] [Related]
4. Evolution of peroxisome proliferator-activated receptor agonists.
Chang F; Jaber LA; Berlie HD; O'Connell MB
Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
[TBL] [Abstract][Full Text] [Related]
5. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB
Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
[TBL] [Abstract][Full Text] [Related]
6. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
7. Novel peroxisome proliferator activated receptor-alpha agonists.
Fruchart JC
Am J Cardiol; 2007 Dec; 100(11 A):n41-6. PubMed ID: 18047852
[TBL] [Abstract][Full Text] [Related]
8. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
Kravchenko NA; Iarmysh NV
Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
[TBL] [Abstract][Full Text] [Related]
9. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
12. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP
Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566
[TBL] [Abstract][Full Text] [Related]
13. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
Ehrenborg E; Krook A
Pharmacol Rev; 2009 Sep; 61(3):373-93. PubMed ID: 19805479
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
16. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
Desreumaux P; Ghosh S
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():2-9. PubMed ID: 16939423
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
[TBL] [Abstract][Full Text] [Related]
18. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface.
Heikkinen S; Argmann C; Feige JN; Koutnikova H; Champy MF; Dali-Youcef N; Schadt EE; Laakso M; Auwerx J
Cell Metab; 2009 Jan; 9(1):88-98. PubMed ID: 19117549
[TBL] [Abstract][Full Text] [Related]
19. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
20. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
Guri AJ; Hontecillas R; Bassaganya-Riera J
J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
